Treatment of severe attacks of asthma in children with nebulized B2 adrenergic agents.
Selective B2 adrenergic agents given by nebulizer is described as a hospital or office treatment for severe attacks of asthma. Salbutamol and Bronkosol are shown to be effective and safe drugs. The method is a simple alternative to IPPB and is easier to use in small children. The use of long-acting, selective B2 adrenergic drugs by nebulizer is recommended in preference to non-selective and short-acting adrenergic agents like epinephrine and isoproterenol.
D000281:Administration, Intranasal; D000420:Albuterol / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001314:Auscultation; D002648:Child; D002675:Child, Preschool; D004417:Dyspnea / Q000175:diagnosis; D006801:Humans; D007223:Infant; D007528:Isoetharine / Q000627:therapeutic use; D010366:Peak Expiratory Flow Rate; D010656:Phenylephrine / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use*
D013566:Sympathomimetics; D010656:Phenylephrine; D000420:Albuterol; D007528:Isoetharine